| scholarly article | Q13442814 |
| P356 | DOI | 10.4155/TDE.14.24 |
| P8608 | Fatcat ID | release_vfheldga2jcr5evozzp445qhwq |
| P698 | PubMed publication ID | 24998274 |
| P2093 | author name string | Deryl L Troyer | |
| Stefan H Bossmann | |||
| Tej B Shrestha | |||
| Matthew T Basel | |||
| P2860 | cites work | T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia | Q24632975 |
| Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma | Q27309626 | ||
| Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias | Q29622949 | ||
| Development of a tumor-selective approach to treat metastatic cancer | Q33267284 | ||
| Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies | Q33519052 | ||
| Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells | Q33790037 | ||
| Effects of transplantation of adipose tissue-derived stem cells on prostate tumor | Q33879286 | ||
| Tumor cell behaviour modulation by mesenchymal stromal cells. | Q33933894 | ||
| Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells | Q34036456 | ||
| In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB) | Q34073529 | ||
| Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor | Q34280164 | ||
| Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity | Q34326400 | ||
| The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. | Q34374056 | ||
| In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions | Q34374543 | ||
| Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells. | Q34444417 | ||
| A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. | Q34708838 | ||
| Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts | Q35175677 | ||
| Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. | Q35238250 | ||
| A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma | Q35256949 | ||
| A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma. | Q35569028 | ||
| Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. | Q35694284 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model | Q35973436 | ||
| Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy | Q36080465 | ||
| Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth | Q36092153 | ||
| Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma | Q36238078 | ||
| Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects. | Q36339837 | ||
| Regulation of the chemokine receptor CXCR4 by hypoxia | Q36371842 | ||
| Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. | Q36420900 | ||
| A cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer model | Q36641472 | ||
| Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion. | Q36729107 | ||
| A novel magnetic approach to enhance the efficacy of cell-based gene therapies | Q39991136 | ||
| Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma | Q40025607 | ||
| The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. | Q40071382 | ||
| Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma | Q40131868 | ||
| Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses | Q40302572 | ||
| Anti-tumor properties of human-activated macrophages produced in large scale for clinical application | Q40373298 | ||
| Evaluation of monocytes as carriers for armed oncolytic adenoviruses in murine and Syrian hamster models of cancer | Q42412637 | ||
| Cell-based therapeutics: the next pillar of medicine | Q42613853 | ||
| Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo | Q42938990 | ||
| Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy | Q43100976 | ||
| Use of thymidine kinase gene-modified endothelial progenitor cells as a vector targeting angiogenesis in glioma gene therapy | Q43112793 | ||
| Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells | Q43821375 | ||
| Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario | Q44763875 | ||
| Culture expansion induces non-tumorigenic aneuploidy in adipose tissue-derived mesenchymal stromal cells. | Q45211623 | ||
| Use of macrophages to target therapeutic adenovirus to human prostate tumors | Q45866292 | ||
| Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors | Q45869138 | ||
| Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model. | Q45876898 | ||
| Neural progenitor cells lack immunogenicity and resist destruction as allografts. | Q47795672 | ||
| Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions | Q48332627 | ||
| Neural stem cell-based dual suicide gene delivery for metastatic brain tumors | Q48360437 | ||
| Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection | Q48888957 | ||
| Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. | Q50754378 | ||
| Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. | Q51798654 | ||
| Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. | Q53385002 | ||
| TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells | Q36818228 | ||
| Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma | Q36861449 | ||
| Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer. | Q37007509 | ||
| HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion | Q37098976 | ||
| Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy | Q37100179 | ||
| The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma | Q37124552 | ||
| Prodrug cancer gene therapy. | Q37172957 | ||
| A macrophage-nanozyme delivery system for Parkinson's disease | Q37179637 | ||
| Regulation of monocytes and macrophages cell fate. | Q37410303 | ||
| Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model | Q37455627 | ||
| Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? | Q37833578 | ||
| Stem cell based cancer gene therapy | Q37901007 | ||
| Advances in stem cell therapy against gliomas | Q38093919 | ||
| The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery | Q38123806 | ||
| Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer. | Q38343722 | ||
| Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell | Q38436187 | ||
| Immortalized human fetal bone marrow-derived mesenchymal stromal cell expressing suicide gene for anti-tumor therapy in vitro and in vivo. | Q39066355 | ||
| Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer | Q39090413 | ||
| Extracts of Crinum latifolium inhibit the cell viability of mouse lymphoma cell line EL4 and induce activation of anti-tumour activity of macrophages in vitro. | Q39139287 | ||
| Gold nanoparticle-loaded neural stem cells for photothermal ablation of cancer. | Q39164984 | ||
| Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells | Q39170477 | ||
| Inhibition of neuronal nitric oxide synthase activity promotes migration of human-induced pluripotent stem cell-derived neural stem cells toward cancer cells | Q39195109 | ||
| LIGHT delivery to tumors by mesenchymal stem cells mobilizes an effective antitumor immune response. | Q39363049 | ||
| Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses | Q39379509 | ||
| Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma | Q39512141 | ||
| Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy. | Q39545848 | ||
| Computational approach for designing tumor homing peptides. | Q39619566 | ||
| A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models | Q39630653 | ||
| Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth | Q39638959 | ||
| Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. | Q39670726 | ||
| Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis | Q39932687 | ||
| Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. | Q39955301 | ||
| Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs | Q39963975 | ||
| Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells | Q39976240 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 555-567 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Therapeutic delivery | Q26842827 |
| P1476 | title | Cells as delivery vehicles for cancer therapeutics | |
| P478 | volume | 5 |
| Q36049529 | Cell Mediated Photothermal Therapy of Brain Tumors |
| Q88868609 | Enhancing the effects of chemotherapy by combined macrophage-mediated photothermal therapy (PTT) and photochemical internalization (PCI) |
| Q38730553 | In vitro exploration of a myeloid-derived suppressor cell line as vehicle for cancer gene therapy. |
| Q38411357 | Macrophages as nanoparticle delivery vectors for photothermal therapy of brain tumors |
| Q46271837 | Photochemical Internalization Enhanced Macrophage Delivered Chemotherapy |
| Q47892757 | Photothermal Therapy Employing Gold Nanoparticle- Loaded Macrophages as Delivery Vehicles: Comparing the Efficiency of Nanoshells Versus Nanorods |
| Q35904558 | Photothermal enhancement of chemotherapy mediated by gold-silica nanoshell-loaded macrophages: in vitro squamous cell carcinoma study |
| Q61797466 | Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency |
Search more.